Cytotoxic and In Silico Evaluation of Hyrtios erectus Extract Against T47D Breast Cancer Cells: A Potential Marine-Derived Anticancer Agent
Journal of Fundamental and Applied Pharmaceutical Science · 31.08.2025 · 6 (1) · 74-106
DOI: 10.18196/jfaps.v6i1.26988 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Fundamental and Applied Pharmaceutical Science, online erschienen am 31.08.2025. Verfasst von Rollando Rollando. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
Hyrtios erectus is a marine sponge species with promising potential as an anticancer agent. This study aimed to evaluate the cytotoxic activity of Hyrtios erectus extract against T47D breast cancer cells and assess the drug-likeness of its active compounds through in silico approaches. The investigation began with a phytochemical screening of the extract, followed by a cytotoxicity assay using the MTT method. The in silico analysis included PASS prediction, ADMET evaluation, and molecular docking. Phytochemical screening revealed the presence of flavonoids, alkaloids, terpenes, and saponins. The cytotoxicity test yielded an IC₅₀ value of 12.73 ± 1.05 µg/mL and a selectivity index (SI) of 18.16, indicating strong cytotoxic activity and high selectivity towards T47D breast cancer cells. PASS and ADMET analyses predicted that 20 identified compounds possess anticancer potential with low toxicity. Molecular docking results exhibited favorable binding energies for 2-chloro-6-phenyl-8H-quinazolino[4,3-b]-quinazolin-8-one, Echinoclerodane A, and 5-hydroxy-1H-indole-3-carboxylic-acid-methyl-ester, suggesting significant interaction with cancer-related protein targets. These findings support the potential of Hyrtios erectus extract and its bioactive compounds as promising candidates for anticancer drug development.
Zitieren
APA
Rollando, R. (2025). Cytotoxic and In Silico Evaluation of Hyrtios erectus Extract Against T47D Breast Cancer Cells: A Potential Marine-Derived Anticancer Agent. Journal of Fundamental and Applied Pharmaceutical Science, 6(1), 74-106. https://doi.org/10.18196/jfaps.v6i1.26988
Vancouver
Rollando R. Cytotoxic and In Silico Evaluation of Hyrtios erectus Extract Against T47D Breast Cancer Cells: A Potential Marine-Derived Anticancer Agent. Journal of Fundamental and Applied Pharmaceutical Science. 2025;6(1):74-106. doi:10.18196/jfaps.v6i1.26988
BibTeX
@article{Rollando2025,
author = {Rollando, Rollando},
title = {Cytotoxic and In Silico Evaluation of Hyrtios erectus Extract Against T47D Breast Cancer Cells: A Potential Marine-Derived Anticancer Agent},
journal = {Journal of Fundamental and Applied Pharmaceutical Science},
year = {2025},
volume = {6},
number = {1},
pages = {74--106},
doi = {10.18196/jfaps.v6i1.26988}
}
EUVIMED